Reason for hope: the advent of disease-modifying therapies in multiple sclerosis.
O'Connor
P W
PW
Division of Neurology, St. Michael's Hospital, Toronto, Ont.
D002986:Clinical Trials as Topic; D016207:Cytokines / Q000494:pharmacology / Q000627:therapeutic use*; D006233:Persons with Disabilities; D018450:Disease Progression; D016527:Drug Costs; D006801:Humans; D007166:Immunosuppressive Agents / Q000494:pharmacology / Q000627:therapeutic use*; D009103:Multiple Sclerosis / Q000276:immunology* / Q000628:therapy*
D016207:Cytokines; D007166:Immunosuppressive Agents